Actively Recruiting

Age: 18Years +
All Genders
ID05636527

Further Evaluation of Safety and Performance of the NEXUS Aortic Arch Stent Graft System and the Custom-Made NEXUS Multibranch2a Aortic Arch Stent Graft System in an Observational Study

Led by Endospan Ltd. · Updated on 2025-12-04

70

Participants Needed

18

Research Sites

174 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This observational study aims to collect clinical information on the safety and performance of the NEXUS Aortic Arch Stent Graft System and the Custom-Made NEXUS DUO Aortic Arch Stent Graft System for treating aortic aneurysms. The main questions focus on early mortality, safety outcomes, device failure, and procedural and hospitalization details. Participants are treated according to standard care at their institutions. Participants receive treatment per their institution's standard of care using either the NEXUS Aortic Arch Stent Graft System or the custom-made NEXUS DUO Aortic Arch Stent Graft System. The study includes both prospective and retrospective data collection with two groups based on the device used. Follow-up information is collected for up to five years after treatment. During the study, researchers will gather data on mortality at 30 days and 12 months, major adverse events, device failure, and other safety outcomes. Participants will undergo regular follow-up visits to monitor these outcomes and collect hospitalization and procedural information. The study is designed to observe real-world use of these devices and understand their longer-term safety and performance.

CONDITIONS

Brief Title

Further Evaluation of Safety and Performance of the NEXUS Aortic Arch Stent Graft System and the Custom-Made NEXUS Multibranch™ Aortic Arch Stent Graft System

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male and female age 6518 years
  • Indicated for implant of the NEXUS Aortic Arch System or custom-made NEXUS DUO Aortic Arch System according to current instructions for use
  • Already implanted with the NEXUS or NEXUS DUO device since February 2019
  • Able and willing to provide informed consent
  • Not currently enrolled in another investigational study or registry that interferes with this study, except mandatory or purely observational registries
  • Life expectancy exceeds one year according to the investigator
  • Not pregnant or planning to become pregnant
  • Stable renal function for the NEXUS procedure as judged by the physician
  • No co-morbidities or planned surgeries interfering with device implant, such as major cardiac surgery or interventional procedures in the last 90 days, or recent myocardial infarction or stroke
Not Eligible

You will not qualify if you...

  • Currently enrolled in another investigational study or registry that directly interferes with this study, except mandatory or purely observational registries
  • Pregnant or planning to become pregnant
  • Unstable renal function for the NEXUS procedure as judged by the physician
  • Co-morbidities or planned surgeries interfering with device implant, including major cardiac surgery or interventional procedures in the last 90 days, myocardial infarction, or stroke in the last 90 days

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Long-term Monitoring

Duration - Up to 12 months

Participants who have already received the NEXUS or NEXUS DUO device are observed to evaluate safety and device performance over time.

Follow-up visits at 30 days and 12 months after device implantation

Trial Site Locations

Total: 18 locations

1

Cliniques universitaires Saint Luc

Brussels, Belgium, 1200

Actively Recruiting

2

UZ Leuven

Leuven, Belgium, 3000

Actively Recruiting

3

Aretaieio Hospital

Nicosia, Cyprus, Cyprus, 2024

Actively Recruiting

4

APHP Henri Mondor

Paris, France

Actively Recruiting

5

Hôpital Européen Georges Pompidou

Paris, France

Actively Recruiting

6

Immanuel Klinikum Brandenburg, Herzzentrum Brandenburg

Bernau bei Berlin, Brandenburg, Germany, 16321

Actively Recruiting

7

University Hospital Duesseldorf

Düsseldorf, North Rhine-Westphalia, Germany, 40225

Actively Recruiting

8

German Heart Center

Berlin, Germany

Actively Recruiting

9

University Hospital Bonn

Bonn, Germany

Actively Recruiting

10

Evaggelismos General Hospital

Athens, Greece

Actively Recruiting

11

Azienda Socio Sanitaria Territoriale (A.S.S.T.) degli Spedali Civili di Brescia

Brescia, Italy, 25123

Not Yet Recruiting

12

University Hospital Padoua

Padova, Italy

Actively Recruiting

13

Stichting Amsterdam UMC,

Amsterdam, Netherlands, 1081

Actively Recruiting

14

University Medical Center Groningen

Groningen, Netherlands

Not Yet Recruiting

15

Medical University of Warsaw

Warsaw, Poland

Actively Recruiting

16

Hospital Universitario Puerta del Mar

Cadiz, Andalusia, Spain, 11009

Actively Recruiting

17

Hospital Alvaro Cunqueiro Vigo

Vigo, Galicia, Spain, 36312

Actively Recruiting

18

Klinikum Hirslanden, Aorten -und Gefäßzentrum, Zuerich

Zurich, Switzerland

Actively Recruiting

Loading map...

Research Team

N

Natali Yosef

J

Jessica Kleine

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here